JCCC Rated Top 10 Again!

UCLA's Jonsson Comprehensive Cancer Center once again ranks among the top 10 cancer centers in the nation and is rated #1 in Southern California, according to the annual U.S. News & World Report survey. "The Jonsson Cancer Center is known for developing new and more effective targeted therapies to treat cancer and for providing leading-edge experimental treatments to patients," said JCCC Director Judith C. Gasson, Ph.D.

Killing Cancer Cells via Glucose Deprivation

In a unique study, a UCLA research team led by JCCC researcher Thomas Graeber, Ph.D. has investigated how the metabolism of glucose affects cancer cells. Dr. Graeber and his colleagues demonstrated that depriving cells of glucose activates a positive feedback loop that leads to cancer cell death. "These findings illustrate the delicate balance that exists between metabolism and signaling in the maintenance of cancer cell homeostasis," Graeber said. This study also showed the possible implications for therapeutic intervention targeting cancer metabolism. Read more.

Welcome to Our Four New Board Members

Four Los Angeles business and community leaders recently joined the JCCF Board of Directors: Alan Berro, Mary Anne Keshen, Linda Miller Savitt and Clare Suomi. Each Board member will serve a three-year term which began last month. We appreciate their commitment to advancing cancer research at the JCCC and we look forward to their partnership in our efforts to provide more effective therapies for cancer patients everywhere. Learn more about each new Board member here.